We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
ExxonMobil (XOM) Falls on Q2 Earnings Miss, Revenues Beat
Read MoreHide Full Article
Earnings Miss: Irving, TX-based Exxon Mobil Corporation (XOM - Free Report) reported earnings per share at 92 cents, below the Zacks Consensus Estimate of $1.26. Following the underperformance, the stock fell more than 3% in the pre-market trading.
Estimate Revision Trend & Surprise History: Investors should note that the Zacks Consensus Estimate for the quarter has been revised upward over the last seven days.
However, ExxonMobil’s earnings surprise history is not impressive. The company failed to beat the Zacks Consensus Estimate in three of the last four quarters, the average negative earnings surprise being 5.7%.
Revenue: Revenues of $73,501 million were higher than the Zacks Consensus Estimate of $70,252 million.
Key Stats: Production averaged 3.647 million barrels of oil-equivalent per day (MMBOE/d), lower than 3.922 MMBOE/d in the year-ago quarter. Liquid production fell year over year to 2.212 million barrels per day (MMB/D) from 2.269 MMB/D. Also, natural gas production was 8.613 MMCF/d (millions of cubic feet per day), down from 9.920 MMCF/d in the year-ago period.
Zacks Rank: Currently, ExxonMobil has a Zacks Rank #3 (Hold) but that could change following its second-quarter 2018 report which has just released. You can see the complete list of today’s Zacks #1 Rank stocks here.
Check back later for our full write up on this ExxonMobil’s earnings report later!
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
ExxonMobil (XOM) Falls on Q2 Earnings Miss, Revenues Beat
Earnings Miss: Irving, TX-based Exxon Mobil Corporation (XOM - Free Report) reported earnings per share at 92 cents, below the Zacks Consensus Estimate of $1.26. Following the underperformance, the stock fell more than 3% in the pre-market trading.
Estimate Revision Trend & Surprise History: Investors should note that the Zacks Consensus Estimate for the quarter has been revised upward over the last seven days.
However, ExxonMobil’s earnings surprise history is not impressive. The company failed to beat the Zacks Consensus Estimate in three of the last four quarters, the average negative earnings surprise being 5.7%.
Revenue: Revenues of $73,501 million were higher than the Zacks Consensus Estimate of $70,252 million.
Key Stats: Production averaged 3.647 million barrels of oil-equivalent per day (MMBOE/d), lower than 3.922 MMBOE/d in the year-ago quarter. Liquid production fell year over year to 2.212 million barrels per day (MMB/D) from 2.269 MMB/D. Also, natural gas production was 8.613 MMCF/d (millions of cubic feet per day), down from 9.920 MMCF/d in the year-ago period.
Zacks Rank: Currently, ExxonMobil has a Zacks Rank #3 (Hold) but that could change following its second-quarter 2018 report which has just released. You can see the complete list of today’s Zacks #1 Rank stocks here.
Check back later for our full write up on this ExxonMobil’s earnings report later!
Exxon Mobil Corporation Price and EPS Surprise
Exxon Mobil Corporation Price and EPS Surprise | Exxon Mobil Corporation Quote
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>